Quick answer: what blood work to run with peptides
Short version
Peptide blood work starts with a baseline panel drawn in the 2 weeks before your first dose. Then you add the labs that fit your peptide. That means IGF-1 for growth hormone peptides, or A1c, lipase and liver enzymes for GLP-1 drugs. Repeat the labs at week 4 and again at weeks 8 to 12. If a result crosses a red-flag line, stop and see a clinician.
Only a few of these peptides are FDA-approved. Semaglutide, tirzepatide and tesamorelin have drug labels that tell doctors what to check. BPC-157, TB-500, CJC-1295, ipamorelin, MOTS-c, GHK-Cu and Melanotan II are not approved. Retatrutide is still in trials. These have no label, so their lab plans come from how each peptide acts in the body.
Do peptides show up on blood work or drug tests?
Do peptides show up on blood work? Not on the tests most people get. Routine blood work and workplace drug screens do not look for peptides. Sports anti-doping labs are the exception. They use special tests that can find many peptides.
Peptides do change your lab values, though. IGF-1, glucose, A1c, lipids, liver enzymes and lipase can all move. A clinician who sees those shifts without knowing what you take may look for a cause that isn't there.
- Routine blood work (CBC, CMP)
- A CBC counts your blood cells. A CMP checks blood sugar, body salts, and kidney and liver markers. Neither test looks for a peptide in your blood. The numbers can still shift. A GLP-1 can lower your glucose, and a growth hormone peptide can raise it.
- Workplace drug screens
- Do peptides show up on a drug test? Not on a standard one. A 5-panel urine test looks for THC, cocaine, opioids, amphetamines and PCP. A 10-panel test adds drugs such as benzodiazepines, barbiturates and methadone. Peptides are not on these panels.
- Anti-doping labs (WADA)
- Sports testing works another way. Anti-doping labs use mass spectrometry, a test that sorts molecules by weight, and it can find many peptides. The 2026 WADA Prohibited List names BPC-157 under S0, its class for drugs with no approval for human use. CJC-1295, ipamorelin, tesamorelin and GHRP-6 are under S2, and so is TB-500. All of these are banned in and out of competition.
- Tirzepatide
- Does tirzepatide show up in blood work or on a drug test? Not as a drug. Standard drug screens don't look for it. Its effects do show up. Tirzepatide lowers fasting glucose and A1c, and lipids often change as weight comes off. Tell anyone who reads your labs that you take it.
- Semaglutide
- Does semaglutide show up in blood work? Standard drug screens don't test for it. Like tirzepatide, it lowers glucose and A1c. The Ozempic label also reports small average rises in lipase (22%) and amylase (13%) in trials. Those are two enzymes made by the pancreas.
- Retatrutide
- Retatrutide is still in Phase 3 trials, so it has no label yet. It is not on routine drug screens. Expect the same kind of shifts as other GLP-1 drugs. Glucose and A1c fall, lipids change, and liver enzymes may move.
- BPC-157
- Does BPC-157 show up on a drug test? Not on a workplace screen, and routine blood work has no marker for it. Anti-doping labs are a different case. WADA names BPC-157 under S0, so it is banned for tested athletes at all times.
Peptide blood test can also mean C-peptide or BNP
Different test, same word
Some people who search for a peptide blood test want a different test. A C-peptide test shows how much insulin your body makes. Doctors use it to check for diabetes. A BNP test helps diagnose heart failure. Neither one checks for peptide use. This guide is about labs for people who take peptides.
Why a baseline matters and when to draw it
A baseline is your 'before' number. Without it, you can't tell what a peptide changed. Say your IGF-1 is 280 ng/mL after 8 weeks on CJC-1295. That could be a big jump from 150, or no change at all. Only a baseline tells you which.
Fasting glucose works the same way. A reading of 104 mg/dL could be new, or it could have been there for years. Growth hormone peptides can push glucose up, so you need the starting point to judge them. The same goes for lipids and liver enzymes on a GLP-1.
- Draw the baseline within 2 weeks before your first dose.
- Fast 8-12 hours before the draw. Water is fine.
- Draw in the morning, between 7 and 9 AM, so later results line up.
- Skip hard exercise for 48 hours before the draw.
Use the same setup for every repeat draw. Glucose, insulin and cortisol change through the day and after meals. When the conditions match, a change in your numbers is more likely to come from the peptide.
Baseline panel: the 8 tests to run before starting
These eight tests make a solid baseline for most peptides. Treat the list as a starting point to go over with your clinician. Your health history may call for more tests, or for fewer.
Test
Comprehensive metabolic panel (CMP)
What it checks
Glucose, electrolytes, kidney (creatinine, eGFR) and liver enzymes (ALT, AST)
Why it matters for peptides
A broad safety check. It gives you kidney and liver numbers to compare once a GLP-1 or other peptide starts.
Test
CBC with differential
What it checks
Red cells, white cells, platelets
Why it matters for peptides
Flags anemia, infection or low platelets. It is the main baseline for healing peptides and helps spot red flags later.
Test
Lipid panel
What it checks
Total, LDL, HDL cholesterol and triglycerides
Why it matters for peptides
Weight-loss peptides often change cholesterol and triglycerides, and GH peptides can too. You need the start values to see the trend.
Test
HbA1c
What it checks
Average blood sugar over about 3 months
Why it matters for peptides
GLP-1 drugs lower it, and GH peptides can raise it. The baseline shows how far it moved.
Test
Fasting insulin with HOMA-IR
What it checks
Insulin resistance
Why it matters for peptides
GH peptides can raise glucose and insulin. HOMA-IR is a score from fasting glucose and insulin that shows insulin resistance early.
Test
Hormone panel
What it checks
Total and free testosterone, estradiol, SHBG, TSH, free T4, free T3, morning cortisol
Why it matters for peptides
Rules out other causes of tiredness or weight change. It also gives you a thyroid baseline before a GLP-1.
Test
IGF-1
What it checks
Growth hormone axis activity
Why it matters for peptides
The main sign that a GH peptide is working. It also shows when a dose pushes you too high.
Test
Inflammation (hs-CRP, ESR)
What it checks
Systemic inflammation
Why it matters for peptides
A baseline for healing peptides like BPC-157 and TB-500. Both markers rise with injury, infection and illness.
| Test | What it checks | Why it matters for peptides |
|---|---|---|
| Comprehensive metabolic panel (CMP) | Glucose, electrolytes, kidney (creatinine, eGFR) and liver enzymes (ALT, AST) | A broad safety check. It gives you kidney and liver numbers to compare once a GLP-1 or other peptide starts. |
| CBC with differential | Red cells, white cells, platelets | Flags anemia, infection or low platelets. It is the main baseline for healing peptides and helps spot red flags later. |
| Lipid panel | Total, LDL, HDL cholesterol and triglycerides | Weight-loss peptides often change cholesterol and triglycerides, and GH peptides can too. You need the start values to see the trend. |
| HbA1c | Average blood sugar over about 3 months | GLP-1 drugs lower it, and GH peptides can raise it. The baseline shows how far it moved. |
| Fasting insulin with HOMA-IR | Insulin resistance | GH peptides can raise glucose and insulin. HOMA-IR is a score from fasting glucose and insulin that shows insulin resistance early. |
| Hormone panel | Total and free testosterone, estradiol, SHBG, TSH, free T4, free T3, morning cortisol | Rules out other causes of tiredness or weight change. It also gives you a thyroid baseline before a GLP-1. |
| IGF-1 | Growth hormone axis activity | The main sign that a GH peptide is working. It also shows when a dose pushes you too high. |
| Inflammation (hs-CRP, ESR) | Systemic inflammation | A baseline for healing peptides like BPC-157 and TB-500. Both markers rise with injury, infection and illness. |
Labs by peptide type
Add these labs to the baseline panel based on the peptide you take. Each row matches the Blood Tests section on that peptide's protocol page. If you take two classes, run the labs for both, and count shared tests like A1c once.
If you're looking for a GLP-1 blood test, use the GLP-1 row. It is also the list to bring up before you start Wegovy, Ozempic, Mounjaro or Zepbound.
Class
GH secretagogues
Peptides
CJC-1295, ipamorelin, tesamorelin, sermorelin, MK-677, GHRP-2/6, hexarelin
Add these labs
IGF-1, fasting glucose and insulin, HbA1c, lipids; prolactin (GHRP-2/6); morning cortisol (GHRP-6, hexarelin). Tesamorelin raised IGF-1 about 81% in HIV lipodystrophy trials.
Protocol pages
CJC-1295 no DAC, CJC-1295 DAC, Ipamorelin, Tesamorelin, Sermorelin, GHRP-6
Class
GLP-1 / GIP
Peptides
Semaglutide, tirzepatide, retatrutide, cagrilintide stacks
Add these labs
HbA1c, fasting glucose, lipids, ALT/AST, lipase/amylase, creatinine/eGFR, TSH. Calcitonin only if your clinician wants it: the labels say routine calcitonin checks are of uncertain value.
Protocol pages
Class
Healing
Class
Other
Peptides
Melanotan II, MOTS-c, AOD-9604, 5-amino-1MQ, GHK-Cu, Semax, Selank
Add these labs
Melanotan II: blood pressure, skin and mole checks. MOTS-c, AOD-9604, 5-amino-1MQ: glucose, insulin, A1c, lipids. GHK-Cu: serum copper and ceruloplasmin, plus zinc. Semax/Selank: CBC, CMP, TSH; cortisol optional.
Protocol pages
Melanotan II, MOTS-c, AOD-9604, 5-Amino-1MQ, GHK-Cu, Semax, Selank
| Class | Peptides | Add these labs | Protocol pages |
|---|---|---|---|
| GH secretagogues | CJC-1295, ipamorelin, tesamorelin, sermorelin, MK-677, GHRP-2/6, hexarelin | IGF-1, fasting glucose and insulin, HbA1c, lipids; prolactin (GHRP-2/6); morning cortisol (GHRP-6, hexarelin). Tesamorelin raised IGF-1 about 81% in HIV lipodystrophy trials. | CJC-1295 no DAC, CJC-1295 DAC, Ipamorelin, Tesamorelin, Sermorelin, GHRP-6 |
| GLP-1 / GIP | Semaglutide, tirzepatide, retatrutide, cagrilintide stacks | HbA1c, fasting glucose, lipids, ALT/AST, lipase/amylase, creatinine/eGFR, TSH. Calcitonin only if your clinician wants it: the labels say routine calcitonin checks are of uncertain value. | Semaglutide, Tirzepatide, Retatrutide, Cagrilintide |
| Healing | BPC-157, TB-500, KPV | CBC, CMP, hs-CRP, ESR | BPC-157, TB-500, KPV |
| Other | Melanotan II, MOTS-c, AOD-9604, 5-amino-1MQ, GHK-Cu, Semax, Selank | Melanotan II: blood pressure, skin and mole checks. MOTS-c, AOD-9604, 5-amino-1MQ: glucose, insulin, A1c, lipids. GHK-Cu: serum copper and ceruloplasmin, plus zinc. Semax/Selank: CBC, CMP, TSH; cortisol optional. | Melanotan II, MOTS-c, AOD-9604, 5-Amino-1MQ, GHK-Cu, Semax, Selank |
The semaglutide and tirzepatide labels carry a boxed warning about thyroid C-cell tumors seen in rodents. People with a personal or family history of medullary thyroid cancer or MEN 2 should not take them. That history matters more than any lab, so tell your clinician about it.
GHK-Cu carries copper, so copper and ceruloplasmin (the protein that carries copper in blood) show if levels are building up. Copper and zinc compete in the body, which is why zinc is often checked with them.
What labs do I need for my stack?
For a stack, combine the labs for each peptide and run each test once. Take a common question: what blood tests do I need if I'm taking reta, GHK-Cu, BPC-157 and TB-500? Retatrutide brings the GLP-1 labs. GHK-Cu adds copper. BPC-157 and TB-500 add inflammation markers and a CBC. The first row lists the full set.
Stack
Retatrutide + GHK-Cu + BPC-157/TB-500
Labs to run
HbA1c, fasting glucose, lipids, CMP (covers ALT/AST and eGFR), lipase/amylase, TSH, CBC, hs-CRP, ESR, serum copper and ceruloplasmin, zinc
Guide
Stack
Tirzepatide alone
Labs to run
HbA1c, fasting glucose, lipids, CMP, lipase/amylase, TSH; calcitonin if your clinician wants it
Guide
Stack
Semaglutide alone
Labs to run
HbA1c, fasting glucose, lipids, CMP, lipase/amylase, TSH; calcitonin if your clinician wants it
Guide
Stack
Retatrutide + MOTS-c
Labs to run
HbA1c, fasting glucose and insulin, lipids, CMP, lipase/amylase, TSH; CK optional
Guide
Stack
CJC-1295 + ipamorelin
Labs to run
IGF-1, fasting glucose and insulin, HbA1c, lipids
Stack
Tesamorelin + ipamorelin
Labs to run
IGF-1, fasting glucose and insulin, HbA1c, lipids
Stack
KLOW (GHK-Cu, KPV, BPC-157, TB-500) and GLOW (GHK-Cu, BPC-157, TB-500)
Labs to run
CBC, CMP, hs-CRP, ESR, serum copper and ceruloplasmin, zinc
Guide
Stack
Wolverine (BPC-157 + TB-500)
Labs to run
CBC, CMP, hs-CRP, ESR; CK (a muscle enzyme) if you train hard
Guide
Stack
MOTS-c
Labs to run
CMP, HbA1c, fasting glucose and insulin, lipids
Guide
| Stack | Labs to run | Guide |
|---|---|---|
| Retatrutide + GHK-Cu + BPC-157/TB-500 | HbA1c, fasting glucose, lipids, CMP (covers ALT/AST and eGFR), lipase/amylase, TSH, CBC, hs-CRP, ESR, serum copper and ceruloplasmin, zinc | Retatrutide, GHK-Cu, BPC-157, TB-500 |
| Tirzepatide alone | HbA1c, fasting glucose, lipids, CMP, lipase/amylase, TSH; calcitonin if your clinician wants it | Tirzepatide |
| Semaglutide alone | HbA1c, fasting glucose, lipids, CMP, lipase/amylase, TSH; calcitonin if your clinician wants it | Semaglutide |
| Retatrutide + MOTS-c | HbA1c, fasting glucose and insulin, lipids, CMP, lipase/amylase, TSH; CK optional | Retatrutide + MOTS-c |
| CJC-1295 + ipamorelin | IGF-1, fasting glucose and insulin, HbA1c, lipids | CJC-1295 + ipamorelin stack |
| Tesamorelin + ipamorelin | IGF-1, fasting glucose and insulin, HbA1c, lipids | Tesamorelin + ipamorelin |
| KLOW (GHK-Cu, KPV, BPC-157, TB-500) and GLOW (GHK-Cu, BPC-157, TB-500) | CBC, CMP, hs-CRP, ESR, serum copper and ceruloplasmin, zinc | KLOW stack, GLOW stack |
| Wolverine (BPC-157 + TB-500) | CBC, CMP, hs-CRP, ESR; CK (a muscle enzyme) if you train hard | Wolverine stack |
| MOTS-c | CMP, HbA1c, fasting glucose and insulin, lipids | MOTS-c |
IGF-1 reference ranges by age
IGF-1 is the main lab for growth hormone peptides like CJC-1295, ipamorelin and tesamorelin. These peptides make your body release more growth hormone. Growth hormone then tells the liver to make IGF-1. IGF-1 stays steady in the blood, so it is easier to measure than growth hormone itself.
IGF-1 falls as you age, so labs set a separate range for each age band. A common target on these peptides is the middle to upper-middle of your age range. If you go past the upper limit for your age, talk with your clinician about the dose. On Labcorp's ranges, no adult band after age 20 tops about 355 ng/mL. A result over 400 ng/mL is high at any adult age.
In the EPIC-Heidelberg study, people with very low or very high IGF-1 had higher death rates than people in the middle.
IGF-1 reference ranges by age, Labcorp test 010363 (ng/mL)
Age
21-25
Men (ng/mL)
109-353
Women (ng/mL)
101-347
Age
26-30
Men (ng/mL)
101-307
Women (ng/mL)
91-308
Age
31-35
Men (ng/mL)
95-290
Women (ng/mL)
84-281
Age
36-40
Men (ng/mL)
90-278
Women (ng/mL)
79-259
Age
41-45
Men (ng/mL)
84-270
Women (ng/mL)
74-239
Age
46-50
Men (ng/mL)
81-263
Women (ng/mL)
70-225
Age
51-55
Men (ng/mL)
74-255
Women (ng/mL)
65-216
Age
56-60
Men (ng/mL)
68-247
Women (ng/mL)
60-207
Age
61-65
Men (ng/mL)
64-240
Women (ng/mL)
57-202
Age
66-70
Men (ng/mL)
59-230
Women (ng/mL)
52-196
Age
71-75
Men (ng/mL)
53-222
Women (ng/mL)
48-191
Age
76-80
Men (ng/mL)
45-207
Women (ng/mL)
42-185
Age
81-85
Men (ng/mL)
40-194
Women (ng/mL)
39-177
| Age | Men (ng/mL) | Women (ng/mL) |
|---|---|---|
| 21-25 | 109-353 | 101-347 |
| 26-30 | 101-307 | 91-308 |
| 31-35 | 95-290 | 84-281 |
| 36-40 | 90-278 | 79-259 |
| 41-45 | 84-270 | 74-239 |
| 46-50 | 81-263 | 70-225 |
| 51-55 | 74-255 | 65-216 |
| 56-60 | 68-247 | 60-207 |
| 61-65 | 64-240 | 57-202 |
| 66-70 | 59-230 | 52-196 |
| 71-75 | 53-222 | 48-191 |
| 76-80 | 45-207 | 42-185 |
| 81-85 | 40-194 | 39-177 |
Labcorp ranges on the IDS-iSYS assay, checked November 2026. Labcorp lists ages 18, 19 and 20 on their own, with higher ranges. Other labs and assays use different numbers, so compare your result to the range printed on your own report.
When to draw: blood work timeline
When
Week 0 (baseline)
What to run
Full baseline panel
When
Week 4
What to run
Early safety check: CMP, fasting insulin, IGF-1 for GH peptides, lipase for GLP-1s, CBC
When
Weeks 8-12
What to run
Repeat the full panel
When
Every 12 weeks while continuing
What to run
Repeat the panel matched to your peptide class
When
4-6 weeks after a cycle ends
What to run
IGF-1, A1c, fasting glucose, liver enzymes
| When | What to run |
|---|---|
| Week 0 (baseline) | Full baseline panel |
| Week 4 | Early safety check: CMP, fasting insulin, IGF-1 for GH peptides, lipase for GLP-1s, CBC |
| Weeks 8-12 | Repeat the full panel |
| Every 12 weeks while continuing | Repeat the panel matched to your peptide class |
| 4-6 weeks after a cycle ends | IGF-1, A1c, fasting glucose, liver enzymes |
Dose timing before a draw
- GH secretagogues: draw at least 12-24 hours after the last dose.
- Weekly GLP-1s: draw mid-week or right before the next shot, and keep it the same each time.
- You don't need to stop a peptide before a routine draw. Keeping the same timing each time matters more.
Here is how that looks for someone on weekly tirzepatide who injects on Sundays. They draw a baseline the week before the first shot. At week 4, they draw on Saturday morning, fasted, the day before the next shot. They repeat that same Saturday draw at week 12 and every 12 weeks after. Each result then comes from the same point in the weekly cycle.
Red-flag results: when to stop and call a clinician
Stop and see a clinician
If any result below shows up, pause the peptide and contact a licensed clinician soon. If you also have severe belly pain, yellow skin or eyes, chest pain or trouble breathing, stop and get medical care right away. These lines are warning signs, and only a clinician can find the cause.
Result
ALT/AST
Threshold
Over 5x the upper limit of normal (ULN)
Why it matters
A sign of real liver injury. These enzymes leak out of damaged liver cells.
Result
Hy's law
Threshold
ALT over 3x ULN plus bilirubin over 2x ULN
Why it matters
This pattern points to drug-induced liver injury that can turn serious.
Result
eGFR
Threshold
Down more than 25% from baseline
Why it matters
Your kidneys are filtering less. Fluid loss from GLP-1 vomiting or diarrhea is one cause.
Result
Fasting glucose
Threshold
Over 200 mg/dL
Why it matters
This is in the diabetes range. GH peptides and MK-677 can push glucose up.
Result
HbA1c
Threshold
Over 8.0%
Why it matters
Blood sugar has run high for about 3 months.
Result
IGF-1
Threshold
Over 1.5x the age-adjusted upper limit
Why it matters
The GH axis is being pushed far past the normal range for your age.
Result
Lipase
Threshold
Over 3x ULN with upper-belly pain
Why it matters
Pain plus high lipase can mean pancreatitis, a warning on GLP-1 labels.
Result
Platelets
Threshold
Under 100,000 per µL
Why it matters
Low platelets raise the risk of bleeding and bruising.
Result
Hemoglobin
Threshold
Down more than 2 g/dL
Why it matters
A drop this size can mean blood loss or anemia.
Result
Potassium
Threshold
Over 5.5 or under 3.0 mmol/L
Why it matters
Too high or too low can upset your heart's rhythm.
| Result | Threshold | Why it matters |
|---|---|---|
| ALT/AST | Over 5x the upper limit of normal (ULN) | A sign of real liver injury. These enzymes leak out of damaged liver cells. |
| Hy's law | ALT over 3x ULN plus bilirubin over 2x ULN | This pattern points to drug-induced liver injury that can turn serious. |
| eGFR | Down more than 25% from baseline | Your kidneys are filtering less. Fluid loss from GLP-1 vomiting or diarrhea is one cause. |
| Fasting glucose | Over 200 mg/dL | This is in the diabetes range. GH peptides and MK-677 can push glucose up. |
| HbA1c | Over 8.0% | Blood sugar has run high for about 3 months. |
| IGF-1 | Over 1.5x the age-adjusted upper limit | The GH axis is being pushed far past the normal range for your age. |
| Lipase | Over 3x ULN with upper-belly pain | Pain plus high lipase can mean pancreatitis, a warning on GLP-1 labels. |
| Platelets | Under 100,000 per µL | Low platelets raise the risk of bleeding and bruising. |
| Hemoglobin | Down more than 2 g/dL | A drop this size can mean blood loss or anemia. |
| Potassium | Over 5.5 or under 3.0 mmol/L | Too high or too low can upset your heart's rhythm. |
How to read your results
Each result on your report comes with a reference range. The lab builds it from healthy people, and it covers the middle 95% of them. So about 1 in 20 healthy people will land a bit outside the range on any one test. A flag means a result needs a look. It does not always mean something is wrong.
Some clinics and websites use tighter 'optimal' ranges. These come from different studies and opinions, so they often disagree with each other. An optimal range can be a fair goal. It is not a diagnosis, and on its own it is a weak reason to change a dose.
One odd number is rarely a crisis. Results move from day to day for normal reasons. Being low on water can raise kidney markers, and a hard workout can raise AST for a few days. A late, heavy meal can raise triglycerides. Compare each result with your own baseline, and look at the trend over two or three draws.
If a result is off but below the red-flag line, retest before you act. Use the same lab, the same time of day and the same fasting window. Ask your clinician how soon to retest. If the second result is back in range, the first one was likely noise.
Where to get tested and what it costs
You can get peptide blood work through a doctor, by ordering your own lab tests, or with an at-home kit. A venous draw at a lab, where blood comes from a vein in your arm, covers every test on this page. At-home kits are easier to repeat but test fewer things.
Option
Doctor-ordered venous draw
How it works
A clinician orders a panel; blood is drawn at a lab, often covered by insurance
Best for
Full panels (CBC, lipase, calcitonin)
Watch out for
Insurance may not pay for labs tied to an unapproved peptide, and some doctors won't order them.
Option
Self-pay lab order (Quest, Labcorp)
How it works
Order online, walk in for a venous draw
Best for
Baseline and follow-up without a clinician visit
Watch out for
You pay per test, so add up the prices first. New York, New Jersey and Rhode Island limit self-ordered tests.
Option
At-home kit (SiPhox Health)
How it works
Mail-in kit, self-collected blood
Best for
Repeat tracking of lipids, ApoB, A1c, liver, kidney, thyroid, hormones
Watch out for
Smaller panels; no CBC, lipase or calcitonin; IGF-1 is a $70 add-on
| Option | How it works | Best for | Watch out for |
|---|---|---|---|
| Doctor-ordered venous draw | A clinician orders a panel; blood is drawn at a lab, often covered by insurance | Full panels (CBC, lipase, calcitonin) | Insurance may not pay for labs tied to an unapproved peptide, and some doctors won't order them. |
| Self-pay lab order (Quest, Labcorp) | Order online, walk in for a venous draw | Baseline and follow-up without a clinician visit | You pay per test, so add up the prices first. New York, New Jersey and Rhode Island limit self-ordered tests. |
| At-home kit (SiPhox Health) | Mail-in kit, self-collected blood | Repeat tracking of lipids, ApoB, A1c, liver, kidney, thyroid, hormones | Smaller panels; no CBC, lipase or calcitonin; IGF-1 is a $70 add-on |
SiPhox Health sells an at-home kit that uses a small device on your upper arm to collect blood. SiPhox says results come back in 7 to 10 days. Plans start at $124 per kit plus shipping. They renew on the schedule you pick, monthly up to every 6 months, until you cancel. It is handy for tracking lipids, A1c, thyroid and hormones between lab visits.
SiPhox panels leave out tests that peptide users need: a CBC, lipase, calcitonin, fasting insulin, and full electrolytes like sodium and potassium. SiPhox lists IGF-1 as a $70 add-on. If you take a GLP-1, you still need lipase and a CBC from a venous lab. Some reviewers also say the arm draw hurt more than they expected. Get your baseline at a lab and use a kit for repeat checks. Our SiPhox Health review covers cost, panels and user complaints.
Blood Test Supplies
An at-home kit makes repeat checks easy between lab visits. Get your baseline from a lab draw first, since kits skip tests like a CBC and lipase. If you research peptides, check each supplier's testing records and current prices before you buy.
Recommended Supplies
Use discount code PEPPAL at Peptide Partners checkout. See why we love Peptide Partners.

Peptide Partners Research Catalog

At-Home Blood Test
Research Supplies
Disclosure: supply links may earn PDP a commission at no cost to you.
Affiliate disclosure: PDP may earn a commission from eligible links at no added cost to you. Prices, stock, and testing records can change.
Companion Supplies & Routine Support
How strong is the evidence behind monitoring?
How much weight a lab plan carries depends on the peptide. For approved drugs, the label tells clinicians what to watch. In the FLOW trial, for example, semaglutide slowed kidney decline in people with type 2 diabetes and kidney disease. For unapproved peptides, the plan is a best guess based on how the peptide works and on animal studies.
Peptide
Semaglutide, tirzepatide
Status
FDA-approved
Monitoring evidence
Label-based monitoring
Peptide
Tesamorelin
Status
FDA-approved (HIV lipodystrophy)
Monitoring evidence
Trial-based IGF-1 monitoring
Peptide
Retatrutide
Status
Investigational (Phase 3)
Monitoring evidence
Extrapolated from other GLP-1 class monitoring
Peptide
CJC-1295, ipamorelin
Status
Not approved
Monitoring evidence
GH-axis logic (IGF-1)
Peptide
BPC-157, TB-500
Status
Not approved
Monitoring evidence
Animal data only
Peptide
MOTS-c, GHK-Cu, Melanotan II, Semax, Selank, KPV
Status
Not approved
Monitoring evidence
Limited data
| Peptide | Status | Monitoring evidence |
|---|---|---|
| Semaglutide, tirzepatide | FDA-approved | Label-based monitoring |
| Tesamorelin | FDA-approved (HIV lipodystrophy) | Trial-based IGF-1 monitoring |
| Retatrutide | Investigational (Phase 3) | Extrapolated from other GLP-1 class monitoring |
| CJC-1295, ipamorelin | Not approved | GH-axis logic (IGF-1) |
| BPC-157, TB-500 | Not approved | Animal data only |
| MOTS-c, GHK-Cu, Melanotan II, Semax, Selank, KPV | Not approved | Limited data |
A normal result can't prove an unapproved peptide is safe for you, since its full range of effects isn't known yet.
Next steps
Book a baseline draw for the 2 weeks before your first dose. Then find your peptide in all protocols and check the Blood Tests section on its page for the exact markers. The peptide dosage chart lists every peptide and stack in one place, with a link to each guide. Bring every result to a licensed clinician, and keep copies so you can compare trends over time.
Peptide blood work FAQ
Q1: What blood tests should I get before starting peptides?
Get a baseline panel in the 2 weeks before your first dose. It covers a CMP, a CBC, a lipid panel, HbA1c, fasting insulin, a hormone panel, IGF-1 and hs-CRP. Then add the labs for your peptide. GH peptides need IGF-1 and glucose. GLP-1 drugs need lipase and liver enzymes. Healing peptides need inflammation markers. Go over the list with a clinician.
Q2: How often should I get blood work on peptides?
A common schedule has five checkpoints. Draw a baseline before you start and a short safety check at week 4. Repeat the full panel at weeks 8 to 12. While you stay on the peptide, repeat your class panel every 12 weeks. After a cycle ends, check IGF-1, A1c, fasting glucose and liver enzymes 4 to 6 weeks later.
Q3: Should I stop peptides before a blood draw?
No, not for a routine monitoring draw. Keep your timing the same each time instead. For GH peptides, draw at least 12 to 24 hours after your last dose. For weekly GLP-1 shots, draw at the same point in your week each time, such as the morning before your next shot. Ask your clinician if a test needs a different plan.
Q4: Can I do peptide blood work at home?
Yes, for some markers. At-home kits like SiPhox Health cover lipids, A1c, liver, kidney, thyroid and hormones. They don't include a CBC, lipase or calcitonin, and IGF-1 costs extra. Use a kit for repeat checks, and get your first panel from a venous draw at a lab. Our SiPhox Health review covers the kit in detail.
Q5: What IGF-1 level should I aim for on a GH secretagogue?
A common target is the middle to upper-middle of the range for your age. If your result goes past the upper limit for your age, talk with your clinician about lowering the dose. A level over about 400 ng/mL is above normal adult ranges at any age. IGF-1 ranges differ by lab, so use the range printed on your own report.
Q6: Why does lipase matter on a GLP-1?
Lipase is an enzyme made by the pancreas. GLP-1 labels warn about pancreatitis, a painful swelling of the pancreas. A small rise is common on these drugs. The Ozempic label reports an average 22% increase in trials. Lipase over 3 times the upper limit with upper-belly pain is a red flag. Stop the drug and get medical care right away.
Q7: Do I need to fast for peptide blood work?
Yes, for most panels. Fast 8 to 12 hours before the draw. Water is fine. Book a morning slot between 7 and 9 AM, since glucose, insulin and cortisol shift through the day. Skip hard exercise for 48 hours before the draw, because it can raise AST and other muscle markers.
Q8: Which lab results mean I should stop peptides?
Stop and call a clinician if ALT or AST is over 5 times normal, eGFR drops more than 25%, fasting glucose is over 200 mg/dL, or A1c is over 8%. The same goes for IGF-1 over 1.5 times your age limit, lipase over 3 times normal with belly pain, or platelets under 100,000. A hemoglobin drop over 2 g/dL or abnormal potassium counts too. The red flags table has the full list.
Q9: Is this medical advice?
No. This guide is for education only. It explains common lab plans and what results can mean, but it can't account for your health history or your medicines. Talk to a licensed clinician before you start a peptide, change a dose or act on a lab result.
Q10: Do peptides show up on a drug test?
Not on a standard workplace test. Urine screens look for drugs like THC, opioids, cocaine and amphetamines, and peptides are not on those panels. Sports testing is different. Anti-doping labs use mass spectrometry and can detect many peptides. WADA bans BPC-157 under S0, and GH releasers like CJC-1295 and ipamorelin under S2. TB-500 is banned too.
Q11: Does tirzepatide show up in blood work?
Not as a drug. Routine labs and standard drug screens don't test for tirzepatide. Its effects do show up. It lowers fasting glucose and A1c, and lipids often change as weight comes off. Tell any clinician who reads your labs that you take it, so they read the changes in context.
Q12: Does semaglutide show up on a drug test?
No. Standard drug screens don't look for semaglutide, and it is not named on the 2026 WADA list. It does change your blood work. Expect lower glucose and A1c over time, and maybe a small rise in lipase and amylase. Your clinician should still know you take it.
Q13: Does BPC-157 show up on a drug test?
Not on a workplace drug test. Routine labs and urine screens don't look for it. Anti-doping labs are different. WADA names BPC-157 under S0, its class for drugs with no approval for human use. That means it is banned in and out of competition. If you compete in a tested sport, treat it as a banned substance.
Sources
- 1. U.S. Food and Drug Administration. Wegovy (semaglutide) injection: prescribing information. FDA (2023)
- 2. U.S. Food and Drug Administration. Ozempic (semaglutide) injection: prescribing information. FDA (2025)Thyroid C-cell boxed warning, calcitonin note, pancreatitis warning, and lipase and amylase changes in trials.
- 3. U.S. Food and Drug Administration. Mounjaro (tirzepatide) NDA 215866: summary review. FDA (2022)
- 4. Perkovic V, Tuttle KR, Rossing P, et al. Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes (FLOW). New England Journal of Medicine (2024)
- 5. Evaluation and treatment of adult growth hormone deficiency: Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism (2011)
- 6. Mukama T, Srour B, Johnson T, et al. IGF-1 and risk of morbidity and mortality from cancer, cardiovascular diseases, and all causes in EPIC-Heidelberg. Journal of Clinical Endocrinology & Metabolism (2023)
- 7. Labcorp. Insulin-like Growth Factor 1 (IGF-1), test 010363: reference intervals. Labcorp
- 8. World Anti-Doping Agency. Prohibited List 2026 (BPC-157 under S0; GH releasing factors under S2.2.4; TB-500 under S2.3). WADA (2026)
- 9. Cleveland Clinic. B-type natriuretic peptide (BNP) test. Cleveland Clinic
Related Dosing Protocols
Educational use only
This guide is an educational reference and is not medical advice. Lab thresholds here are general and may not apply to you. Most peptides discussed are not FDA-approved. Talk to a licensed clinician before starting any peptide or changing a dose based on lab results.
Written by Garret Grant
Founder & Lead Researcher · B.S. Civil Engineering, UCLA
Last updated: November 2026
Human-researched and AI-assisted with full editorial review. I verify sources, protocol interpretation, and final judgments personally. See methodology.
Share this page
See our research first on Google
Add us as a preferred source for Top Stories.
